Not available in English

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-000850-23-FR

Enrollment

Registered

2014-04-04

Start date

2013-11-20

Completion date

Unknown

Last updated

2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

Trade Name: Pneumo23 Pharmaceutical Form: Solution for injection

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: french language, see below Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 12 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: french language, see below

Design outcomes

Primary

Measure	Time frame
Main Objective: french language, see below;Secondary Objective: french language, see below;Primary end point(s): french language, see below;Timepoint(s) of evaluation of this end point: D0, D7, D14, D28, D56	—

Secondary

Measure	Time frame
Secondary end point(s): not applicable;Timepoint(s) of evaluation of this end point: not applicable	—

Countries

France

Contacts

Public ContactSonia GUEGUEN

INSERM

rqrc.siege@inserm.fr+33144236047

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026